News Center

Discover all of the trending news of the Ipsen Group

12 results

Event Group

Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020

David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast…

Neuroscience Patient

EACD 2020: How the use of functional assessments in clinical trials provides meaningful information for physicians treating children with cerebral palsy

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…


Liver Cancer Awareness Month – Rethink liver cancer

October is Liver Cancer Awareness Month and this year we are proud to be supporting…


Ipsen – Q3 2020 Sales Conference Call – Thursday, October 22, 2020

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…


Ipsen announces sales growth over the first 9 months of 2020

Around the world, COVID-19 cases are on the rise again. Despite the challenges presented by…


Breast Cancer Awareness Month: raising awareness with inspirational patient stories

By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer The facts and figures around breast…


Harnessing the power of real-world data for better, more targeted solutions for patients

By David Loew, CEO Innovation to improve patient outcomes doesn’t always resemble the scenes…


Ipsen announces the appointment of new EVP Business Development

September 25, 2020

We are pleased to announce that our Business Development team will be led by Philippe…

Rare diseases

Putting our purpose to the test: what we and the community are learning from our FOP trials

September 16, 2020

By Jim Roach, M.D., Senior Vice President and Global Head, Rare Diseases Therapeutic Area There…

Event Oncology

Ipsen at ESMO 2020: our vision, commitment and top three oncology priorities to better serve patients

September 14, 2020

By David Loew, CEO The annual European Society for Medical Oncology (ESMO) congress is…


Executive Leadership Team Announcement

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product…

Financial information Group

Ipsen announces 3.1% Group Sales Growth, reinstates 2020 guidance

We are pleased to announce a resilient financial performance for H1 2020, despite the…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020